Epigenetic silencing of multiple interferon pathway genes after cellular immortalization

Oncogene. 2003 Jun 26;22(26):4118-27. doi: 10.1038/sj.onc.1206594.

Abstract

Abrogating cellular senescence is a necessary step in the formation of a cancer cell. Promoter hypermethylation is an epigenetic mechanism of gene regulation known to silence gene expression in carcinogenesis. Treatment of spontaneously immortal Li-Fraumeni fibroblasts with 5-aza-2'-deoxycytidine (5AZA-dC), an inhibitor of DNA methyltransferase (DNMT), induces a senescence-like state. We used microarrays containing 12 558 genes to determine the gene expression profile associated with cellular immortalization and also regulated by 5AZA-dC. Remarkably, among 85 genes with methylation-dependent downregulation (silencing) after immortalization, 39 (46%) are known to be regulated during interferon signaling, a known growth-suppressive pathway. This work indicates that gene silencing may be associated with an early event in carcinogenesis, cellular immortalization.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antimetabolites, Antineoplastic / pharmacology
  • Azacitidine / analogs & derivatives*
  • Azacitidine / pharmacology
  • Cell Division
  • CpG Islands
  • DNA (Cytosine-5-)-Methyltransferases / metabolism
  • DNA Methylation
  • Decitabine
  • Down-Regulation
  • Fibroblasts / metabolism
  • Gene Silencing*
  • Humans
  • Interferons / genetics*
  • Interferons / metabolism
  • Oligonucleotide Array Sequence Analysis
  • Oligonucleotides / chemistry
  • Phenotype
  • Promoter Regions, Genetic
  • Reverse Transcriptase Polymerase Chain Reaction
  • Up-Regulation

Substances

  • Antimetabolites, Antineoplastic
  • Oligonucleotides
  • Decitabine
  • Interferons
  • DNA (Cytosine-5-)-Methyltransferases
  • Azacitidine